Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Dr. C. Randall Harrell Announced As Keynote Speaker To Discuss New Burn Pit Injury Treatments

Regenerative Processing Plant,LLC
Posted on: 31 Oct 17

PALM HARBOR, Fla., Oct. 31, 2017 /PRNewswire/ -- Regenerative Processing Plant (RPP) is pleased to announce that Dr. C. Randall Harrell, their Chief Medical Officer (CMO), will be the keynote speaker at the Veteran's Support Services Awards (VSSA) Gala on Veterans Day (November 10, 2017). The event is sponsored by the Mansfield Institute for Public Policy and Social Change, Inc.

Dr. Harrell will discuss the past and future advances in military medicine. Burn pit inhalation injuries in soldiers and veterans will be discussed, as well as his discovery of the First-in-Class next generation treatment: The PurAcel Inhalation Solution.

Attendees will include many ranking military officials and other notables.

About the Mansfield Institute: The Mansfield Institute for Public Policy and Social Change, Inc. is a non-profit non-partisan association committed to improving the lives of all young people who seek to better their community through federal, state legislation and public policy development. Go to westandunitedforacause.org to learn more about their efforts.

About Dr. Harrell: Dr. Harrell has been a pioneer in the field of Regenerative Medicine for the past 40 years. His patented, novel platform technologies such as Sterile D-MAPPS and other innovative products allow for a new standard of care for our troops and veterans, and others who suffer from debilitating illnesses.

About Regenerative Processing Plant, LLC: RPP is a BioPharma company that is a pioneer in the rapidly growing field of Regenerative Medicine. Its visionary CMO is Dr. C. Randall Harrell, who invented and developed patent-protected and proprietary next generation platform technologies and a series of novel biologics for both the commercial market as well as the VA and DoD. These innovative products were designed to meet urgent needs in the fields of pulmonary, burns, wound care, pain, orthopedics, and ophthalmology.

If you would like more information about this topic, please contact our COO, Crissy Fellabaum, PhD, at (800) 781-0818 or email at crissy@regenerativeplant.org.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 31/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.